This company has shut down. Chinook Therapeutics is no longer operating — its last tracked round was a Post-IPO Equity in 2022.
Explore the Startup GraveyardChinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Chinook Therapeutics has raised $105.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2022.
Chinook Therapeutics's investors include Janus Henderson Investors, Samsara BioCapital, Rock Springs Capital, OrbiMed, Versant Ventures.
Chinook Therapeutics is headquartered in Vancouver, Canada.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Chinook Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chinook Therapeutics — Funding & Investors." VCBacked, May 24, 2022, https://www.vcbacked.co/company/chinook-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Chinook Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/chinook-therapeutics
{{cite web |title=Chinook Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/chinook-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated